CAS: 2039-66-9; 2-(2-Aminoethyl)Phenol

上下游产品

CAS号3156-43-2 反-2-羟基-β-硝基苯乙烯 | CAS号2045-79-6 2-甲氧基苯乙胺 | CAS号73971-96-7 1-(β-Aminoethyl... | CAS号72251-59-3 3-(β-Aminoethyl... | CAS号14714-50-2 2-羟基苯乙腈 | CAS号90-02-8 水杨醛 | CAS号5896-17-3 2-苄氧基苯甲醛 | CAS号22446-40-8 2-(2-hydroxyphe... | CAS号135-02-4 邻甲氧基苯甲醛 | CAS号20286-84-4 tert-butyl 2-hy...

3-(2-羟基苯基)丙酰胺置于sodium Hypochlorite体系中,化学反应生成2-(2-氨基乙基)苯酚
参考文献:De233551
标题:De233551

专利信息

专利号:US-RE31624-E
优先权日:1979-11-26
标 题 :Method of treating inflammation
摘要:A method of treating inflammation and inhibiting prostaglandin synthesis employing substituted 2-(arylmethoxy)phenol compounds.

专利号:US-4244956-A
优先权日:1979-11-26
标题 :Method of treating inflammation
发明人：DEWHIRST FLOYD E
权利人:FORSYTH DENTAL INFIRMARY
摘要:A method of treating inflammation and inhibiting prostaglandin synthesis employing substituted 2-(arylmethoxy)phenol compounds.

专利号:US-2014315915-A1
优先权日:2009-02-09
标题:Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

专利号:US-9522901-B2
优先权日:2005-05-26
标题:Compositions and methods including cell death inducers and procaspase activation
发明人：HERGENROTHER PAUL J; PUTT KARSON S; PETERSON QUINN P; FAKO VALERIE
权利人:UNIV ILLINOIS
摘要:Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3. In embodiments, compositions are capable of activation of procaspase-3.

专利号:US-9643960-B2
优先权日:2009-02-09
标 题:Procaspase activating compounds
发明人：HERGENROTHER PAUL J; PETERSON QUINN PATRICK; HSU DANNY CHUNG; WEST DIANA C; FAN TIMOTHY M; NOVOTNY CHRIS J
权利人:UNIV ILLINOIS
摘要:Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.

专利号:US-2012040995-A1
优先权日:2009-02-09
标 题:Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs